ERAS-601, a potential best-in-class SHP2 inhibitor, is being investigated alone and in combination in the ongoing FLAGSHP-1 Phase 1/1b trial...
Building on strong foundations to take Small Pharma through development to commercial success Peter Rands to take on role as...
CAMBRIDGE, Mass., July 18, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for...
- Positive 12-Month Safety and Efficacy Data from Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment of Wet...
Progress continues apace with multiple trials expected to enter clinic later this year First US patent granted LONDON, July 15,...
TORONTO, ONTARIO, July 15, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna" or the "Company"), a...
SOUTH SAN FRANCISCO, Calif., July 15, 2022 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused...
Bavarian Nordic to supply an additional 2.5 million doses of JYNNEOS® vaccine, bringing deliveries in 2022 and 2023 to a...
On Track for FY 2022 Guidance Q1 2022 revenue rises 3% to €10.3 million Completed phase out of COVID-19 Business...
Globally, women are more at risk for mental health issues than men. Rates of burnout are highest in the U.S....
Nephron Pharmaceuticals Corporation selects Revaly as their design collaboration tool. WEST COLUMBIA, S.C., July 14, 2022 /PRNewswire/ -- ZVerse, an...
As COVID-19 pandemic entered a new phase and changing workforce dynamics reshaped labor market, well-being improved in key well-being and...
DUBLIN, July 14, 2022 /PRNewswire/ -- The "Optical Coherence Tomography (OCT) for Ophthalmology - Global Market Trajectory & Analytics" report has...
WELL forms a new business unit to consolidate its Canadian outpatient clinic businesses into a highly integrated national 'bricks and...
XI'AN China, July 14, 2022 /PRNewswire/ -- Tianlong has launched a campaign together with the Spinal muscular atrophy (SMA) care...
Vancouver, British Columbia--(Newsfile Corp. - July 14, 2022) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" the "Company"), a...
Demonstrates OBDS Device Performance and Bioavailability in Animal ModelsSAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq:...
Chiesi’s Annual and Sustainability Report 2021 is released today;Progress toward business, environmental and social targets is strong;Company is joining forces...
ORANGE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, today announced more details...
Groundbreaking Medical Device Company Unveils AI-Powered Software that Improves Diagnostic Imaging Experience for Young PatientsAUSTIN, Texas, July 14, 2022 (GLOBE...